WHO has set global targets for the elimination of hepatitis B and hepatitis C as a public health threat by 2030. However, investment in elimination programmes remains low. To help drive political commitment and catalyse domestic and international financing, we have developed a global investment framework for the elimination of hepatitis B and hepatitis C. The global investment framework presented in this Health Policy paper outlines national and international activities that will enable reductions in hepatitis C incidence and mortality, and identifies potential sources of funding and tools to help countries build the economic case for investing in national elimination activities. The goal of this framework is to provide a way for countries, particularly those with minimal resources, to gain the substantial economic benefit and cost savings that come from investing in hepatitis C elimination.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/S2468-1253(20)30010-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The trade of illicit cigarettes in Ghana: Insights from a policy synthesis and qualitative study.
Tob Prev Cessat
January 2025
School of Public Health, Kwame Nkrumah University of Science & Technology, Kumasi, Ghana.
The illicit trade of tobacco products trade continues to challenge tobacco control efforts in several African countries, including Ghana. Ghana recently ratified the Framework Convention for Tobacco Control (FCTC) Protocol to Eliminate Illicit Trade in Tobacco Products ('the Protocol'). This Protocol aims to eliminate all kinds of illicit tobacco.
View Article and Find Full Text PDFThe case for data sharing in traditional, complementary, and integrative medicine research.
Integr Med Res
March 2025
Institute of General Practice and Interprofessional Care, University Hospital Tübingen, Tübingen, Germany.
Traditional, complementary, and integrative medicine (TCIM) research encompasses a diverse range of health practices rooted in various cultural, philosophical, and historical frameworks. As global interest in conducting research in this field grows, the need for rigorous research to support the integration of evidence-based TCIM therapies into mainstream healthcare has become essential. Data sharing is critical to advancing TCIM research by enhancing reproducibility, fostering interdisciplinary collaboration, promoting ethical practices, and addressing global health challenges.
View Article and Find Full Text PDFMeteorin-like protein plasma levels are associated with worse outcomes in de novo heart failure.
Eur J Clin Invest
January 2025
Cellular and Molecular Cardiology Research Unit, IDIS, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
Background And Aims: Meteorin-like protein (Metrnl) has been recently suggested as a new adipokine with protective cardiovascular effects. Its circulating levels in patients seem to be associated with heart failure (HF), although with contradictory results. Our aim was to ascertain whether this adipokine could estimate the prognosis of HF in de novo HF (DNHF) patients.
View Article and Find Full Text PDFAssessing the development of health technology assessment in Iran: a policy analysis using Kingdon's Multiple streams framework: a qualitative study.
BMC Public Health
January 2025
Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Background: Health Technology Assessment (HTA) is crucial for optimizing healthcare investments and improving system efficiency. In Iran, the rising costs of healthcare technologies and systemic inefficiencies have highlighted the need for a structured HTA framework. However, despite academic discussions, HTA has not yet been fully integrated into formal health policy.
View Article and Find Full Text PDFFirst-time use of electronic patient-reported outcome measures in a cluster randomized trial: a qualitative study.
J Patient Rep Outcomes
January 2025
Department of Health Sciences Ålesund, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Ålesund, Norway.
Background: Although there is clear evidence supporting the beneficial effects of regularly assessing patient-reported outcomes (PROs), the comprehensive integration of patient-reported outcome measures (PROMs) into routine cancer care remains limited. This study aimed to explore the facilitators and barriers encountered by principal investigators (PIs) (oncologists) and study nurses during the implementation of the Eir ePROM within a cluster randomized trial (c-RCT) in cancer outpatient clinics. Additionally, we sought to examine the influence of Eir on the working routines of the participants.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!